Not 💯 on why it appears to be kept below 75M mcap. From what we have seen the SP won't budge regardless of the PR. 🤷♂️🤷♂️ I must bear in mind none of the PR provides any tangible value to the company but I would have expected to be sitting much higher than our 75Mcap ceiling. The recent data is a huge first step and lays a foundation for Kitov as a oncology' focused pharma company.
Let's see what any new revelations reveal about our short term SP